Please note that we would like to update IRIS for Vfend to show that we have withdrawn/deleted 7 presentations from its label however the witdhrawal notitication does not allow us to withdraw certain presentations (it would withdraw the whole product which we do not want). Can you please provide guidance what we should select to report this through IRIS?
The presentations in question are for all EU member states:
EU/1/02/212/010 - 50 mg Tablet, Film Coated | 1 x 2 Units Bottle
EU/1/02/212/011 - 50 mg Tablet, Film Coated | 1 x 30 Units Bottle
EU/1/02/212/012 - 50 mg Tablet, Film Coated | 1 x 100 Units Bottle
EU/1/02/212/022 - 200 mg Tablet, Film Coated | 1 x 2 Units Bottle
EU/1/02/212/023 - 200 mg Tablet, Film Coated | 1 x 30 Units Bottle
EU/1/02/212/024 - 200 mg Tablet, Film Coated | 1 x 100 Units Bottle
EU/1/02/212/027 - 200 mg; Injection, Powder, Lyophilized, For Solution | 1 x 200 mg Type I - Clear glass Vial with Rubber stopper/Aluminum seal/Flip off plastic cap
thank you for your kind advice and help,